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Available online 9 August 2016While cigarette smoking is a well-recognized cause of elevated white blood cell (WBC) count, studies on longi-
tudinal effect of smoking cessation on WBC count are limited. We attempted to determine causal relationships
between smoking and elevated WBC count by retrospective cross-sectional study consisting of 37,972 healthy
Japanese adults who had a health check-up between April 1, 2008 andMarch 31, 2009 and longitudinal study in-
volving 1730 current smokers who had more than four consecutive annual health check-ups between April 1,
2007 and March 31, 2012.
In the cross-sectional study, younger age, male gender, increased body mass index, no alcohol habit, current
smoking, and elevated C-reactive protein level were associated with elevated WBC count. Among these factors,
current smoking had themost signiﬁcant associationwith elevatedWBC count. In subgroup analyses byWBCdif-
ferentials, smoking was signiﬁcantly associated with elevated counts of neutrophils, lymphocytes, monocytes,
eosinophils, and basophils. Ex-smoking was not associated with elevated WBC count. In the longitudinal study,
both WBC and neutrophil counts decreased signiﬁcantly in one year after smoking cessation and remained
down-regulated for longer than next two years. There was no signiﬁcant change in either WBC or neutrophil
count in those who continued smoking.
These ﬁndings clearly demonstrated that current smoking is strongly associated with elevated WBC count and
smoking cessation leads to recovery of WBC count in one year, which is maintained for longer than subsequent
two years. Thus, current smoking is a signiﬁcant and reversible cause of elevated WBC count in healthy adults.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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It is not uncommon to ﬁnd leukocytosis in otherwise healthy indi-
viduals. Epidemiological data indicate that cigarette smoking is associ-
ated with elevated white blood cell (WBC) count (Petitti and Kipp,
1986; Yarnell et al., 1987; Schwartz and Weiss, 1991; Schwarz and
Weiss, 1994; Freedman et al., 1996; Sunyer et al., 1996; Van Tiel et al.,
2002; Fröhlich et al., 2003; Smith et al., 2003; Lao et al., 2009). In addi-
tion, a variety of factors such as younger age (Schwartz and Weiss,
1991; Nagasawa et al., 2004), male gender (Schwartz and Weiss,
1991; Brown et al., 2001), increased body mass index (BMI)
(Schwartz and Weiss, 1991; Nagasawa et al., 2004; Herishanu et al.,
2006; Jee et al., 2005; Imano et al., 2007), high blood pressure (HBP)
(Nagasawa et al., 2004; Brown et al., 2001; Jee et al., 2005; Imanopital, 1-9 Akashi-cho, Chuo-ku,
. This is an open access article underet al., 2007; Lee et al., 2009), hyperlipidemia (Nagasawa et al., 2004;
Jee et al., 2005), diabetes (Nagasawa et al., 2004; Jee et al., 2005), and
decreased alcohol consumption (Schwartz and Weiss, 1991; Nakanishi
et al., 2003) have been reported to be associated with elevated WBC
count. On the other hand, elevated WBC count has been reported to
be an independent predictor of coronary heart disease (CHD) and car-
diovascular disease (CVD) (Brown et al., 2001; Madjid et al., 2004)
and reduction in the WBC counts may be related to the reduction in
the CHD and CVD risks.
A number of studies have reported that smoking cessation leads to a
decrease in WBC count which appears to be associated with the dura-
tion of the smoking abstinent (Petitti and Kipp, 1986; Yarnell et al.,
1987; Schwartz and Weiss, 1991; Schwarz and Weiss, 1994; Van Tiel
et al., 2002; Fröhlich et al., 2003; Smith et al., 2003; Lao et al., 2009;
Kawada, 2004; Ishizaka et al., 2007; Parry et al., 1997). However, most
of these studies are based on cross-sectional studies. Although some
prospective studies have shown that smoking cessation with nicotine
replacement therapy (Jensen et al., 1998; Eliasson et al., 2001) orthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(Sunyer et al., 1996; Green and Harari, 1995) led to a time-dependent
decrease in WBC count which was apparent as early as eight weeks
after cessation, there have been few reports on longitudinal effects of
smoking cessation on WBC count. Especially, there is only one cross-
sectional studywhich investigated the association of smoking cessation
and WBC count in Japanese cohort but longitudinal effect of smoking
cessation on WBC count in Asian population has not been studied
(Kawada, 2004).
The aim of this study was to determine causal relationship between
smoking and elevated WBC count in a large cohort of healthy Japanese
adults. Our results adds to the literature further evidence of the causal
relationship between smoking and WBC count and demonstrate that
the effect of smoking on WBC count is reversible within one year after
smoking cessation.
2. Patients and methods
This study is a retrospective observational study approved by The
Ethics Committee of St. Luke's International Hospital and all the individ-
uals had approved the use of their data.
2.1. Cross-sectional study
A total of 40,279 healthy adults (≥20 years old) had a general health
check-up from April 1, 2008 to March 31, 2009 in the department of
preventive medicine afﬁliated with a tertiary referral hospital in Tokyo
Japan. Subjects who had known hematological and/or solid tumors
and 50 subjects with incomplete questionnaire were excluded, leaving
37,972 individuals who comprised the subjects of the retrospective
cross-sectional study (Fig. 1A). Age, gender, height, body weight, com-
plete blood cell count with differentials of WBC, and C-reactive protein
(CRP) level were collected from medical records. BMI was categorized
into three categories; b22 kg/m2, ≤22 kg/m2 and b25 kg/m2, and
25 kg/m2 ≤. BMI b 22 kg/m2 was used as reference in logistic regression
analysis. Smoking history including number of cigarettes per day, yearsFig. 1. Study ﬂow diagrams of cross-sectioof smoking, and alcoholic consumption historywere collected from self-
administered questionnaire for the general health check-up. Smoking
factors were categorized into current, past, and non-smoker. WBC and
its differentials of individuals who had quitted smoking (ex-smokers)
and current smokerswere comparedwith thosewhohad never smoked
(never smokers). WBC counts equal to or N9.0 × 109/L were deﬁned to
be increased. For eachdifferential ofWBC, neutrophil counts N 7.5×109/
L, monocyte counts N 1.0 × 109/L, eosinophil counts N 0.7 × 109/L, and
basophil counts N 0.15 × 109/L were deﬁned to be increased.
2.2. Longitudinal study
Healthy adult smokers who had more than four consecutive annual
health check-ups from April 1, 2007 to March 31, 2012 in the same in-
stitution were studied. Among 83,752 individuals who had health
check-ups during this period, 25,003 had more than four consecutive
annual health check-ups. CRP data on one ormore occasionsweremiss-
ing in 2822 individuals and they were excluded. Four thousand ﬁve
hundred ﬁfty-seven patients with hematological and/or solid tumors,
who were taking steroids and/or whose CRP value was equal to or
above 0.3 mg/dL as well as two individuals with incomplete date were
excluded, thus leaving 17,622 individuals. Fifteen thousand eight hun-
dred ninety-two individuals who had never smoked, who had a
smoking history but quitted smoking before the study period, and
who quitted smoking after the ﬁrst visit but resumed afterward before
the fourth visit were also excluded. The remaining 1730 individuals
were current smokers at their ﬁrst visit, of whom 1499 continued
smoking for longer than three years while 231 quitted smoking within
one year after the ﬁrst visit and remained abstinent from smoking
until the fourth visit (Fig. 1B). Longitudinal changes of theWBC and dif-
ferential counts were evaluated retrospectively.
2.3. Hematological analyses
Fasting venous blood sampleswere drawn from all subjects into vac-
uum tube containing EDTA. WBC count and differentials werenal (A) and longitudinal (B) studies.
Table 3
Characteristics of the participants.
Quitters
(n=
231)
Continuing smokers (n=
1499)
P value
Age, mean (SD) 51 (10) 48 (10) 0.0003
Male gender, n (%) 172 (74) 1092 (73) 0.63
BMI (kg/m2), mean (SD) 23 (2.9) 23 (3.2) 0.43
Cigarettes/day, mean (SD) 13 (8) 18 (10) b0.0001
WBC count (109/L), mean
(SD)
5.64
(1.59)
6.03 (1.67) 0.0009
BMI, body mass index; WBC, white blood cell; SD, standard deviation.
Table 1
Factors associated with increased white blood cell count.
Odds ratio 95% CI P value
Age 0.98 0.98–0.99 b0.0001
Male gender 1.60 1.30–1.96 b0.0001
BMI b 22 1
22 ≤ BMI b 25 1.49 1.21–1.83 0.0002
25 ≤ BMI 2.15 1.74–2.65 b0.0001
Alcohol habit 0.68 0.57–0.80 b0.0001
Ex-smoker 1.10 0.86–1.42 0.44
Current smoker 6.60 5.43–8.02 b0.0001
CRP (mg/dL) 2.22 2.00–2.47 b0.0001
Hosmer-Lemeshow test, P= 0.002.
BMI, body mass index; CRP, C-reactive protein; CI, conﬁdence interval.
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GEN-S (until February 2009) or SysmexXE-2100 (afterMarch2009) au-
tomated hematology analyzer.
2.4. Statistical analyses
Comparisons of continuous variable and proportions were per-
formed using unpaired Student's t-test and Fisher's exact test, respec-
tively. In the cross-sectional study, the associations of each
independent variable with elevated WBC count and differential counts
were analyzed by simple and multivariate logistic regression analyses.
In the longitudinal analysis, paired Student's t-test was applied. Simple
andmultivariate logistic regressionswere conducted using the outcome
of decreasedWBC count on the second and fourth visits compared with
thebaselineWBCcount.Modelﬁt ofmultivariate logistic regressionwas
checked by Hosmer-Lemeshow test.
All analyses were two tailed and P values b 0.05 were considered to
be statistically signiﬁcant. All variables with P value b 0.2 in simple re-
gression were included in multivariate mode. All analyses were per-
formed using JMP® version 10 (SAS Institute, Inc. Cary, NC, USA) and
STATA® version 14.1 (StataCorp, College Station, TX, USA).
3. Results
3.1. Cross-sectional study
In the cross-sectional study, multivariate analysis revealed that ele-
vated WBC count was signiﬁcantly associated with younger age, male
gender, increased BMI, no habit of drinking alcohol, current smoking,
and elevated CRP (Table 1). The factor most strongly associatedwith el-
evatedWBC countwas current smoking (odds ratio [OR], 6.60; 95% con-
ﬁdence interval [CI], 5.43–8.02). Ex-smoking was not associated with
elevated WBC count.
The associations of these factors with each WBC differential were
also studied (Table 2). Current smoking was signiﬁcantly associated
with increase of all differentials including neutrophils, lymphocytes,Table 2
Factors associated with increase of white blood cell differentials.
Neutrophils Lymphocytes
OR 95% CI OR 95% CI
Age 0.98 0.96–0.99 1.0 0.96–1.04
Male gender 1.6 1.1–2.4 6.5 1.5–45
BMI b 22 1 1
22 ≤ BMI b 25 1.2 0.8–1.7 1.0 0.3–3.1
25 ≤ BMI 1.3 0.9–1.8 1.0 0.3–3.3
Alcohol habit 1.0 0.7–1.4 0.5 0.2–1.4
Ex-smoker 0.9 0.6–1.5 1.8 0.4–7.8
Current smoker 3.9 2.8–5.6 6.1 1.9–24
CRP (mg/dL) 1.9 1.7–2.1 1.4 0.5–1.8
P value of HL test 0.15 0.51
BMI, body mass index; CRP, C-reactive protein; OR, odds ratio; CI, conﬁdence interval; HL, Hosmonocytes, eosinophils, and basophils. Elevated CRP was associated
with increase of neutrophils and monocytes but not with that of lym-
phocytes, eosinophils, and basophils. Male gender was associated with
elevated neutrophil, lymphocyte, monocyte, and eosinophil counts.
BMI was not associated with increase of any differentials in spite of
the positive association with total WBC count (Tables 1 and 2).3.2. Longitudinal study
In the longitudinal study, baseline characteristics of 1730 individuals
who were current smokers at their ﬁrst visits are presented in Table 3.
231 individuals of 1730 smokers quitted smoking within one year
after the ﬁrst visit, and continued to be abstinent from smoking until
the fourth visit (quitters). The remaining 1499 smokers continued
smoking for longer than four years after the ﬁrst visit (continuing
smokers). The baseline WBC counts of the quitter were signiﬁcantly
lower than those of continuing smokers (Table 3). The quitterswere sig-
niﬁcantly older and smoked less cigarettes per day than the continuing
smokers.
In one year after the ﬁrst visit, a signiﬁcant decrease in WBC count
(mean, 5.374 × 109/L) from baseline (mean, 5.642 × 109/L) was ob-
served in the quitters' group (P = 0.001) (Fig. 2A). The decrease in
WBC count remained signiﬁcant compared to the baseline level for
the next two years (P b 0.0001). The meanWBC counts of the continu-
ing smokers did not change either one year after the ﬁrst visit (mean,
6.087× 109/L) or two years afterward (mean, 6.059× 109/L) from base-
line (6.031 × 109/L) (Fig. 2A).
As therewere differences in age, baselineWBC count, number of cig-
arettes per day between quitters and continuing smokers at baseline, lo-
gistic regression analyses were performed including these factors. As
expected, smoking cessation was signiﬁcantly associated with decrease
of WBC count in one year with an adjusted OR of 1.85 (95% CI, 1.39–
2.48) (Table 4) and after the following two years (adjusted OR, 2.54;
95% CI, 1.88–3.46) (Table 5). The higher WBC count at baseline was
also signiﬁcantly associated with decrease in WBC count within one
year after cessation (adjusted OR, 1.37; 95% CI, 1.28–1.46) (Table 4)Monocytes Eosinophils Basophils
OR 95% CI OR 95% CI OR 95% CI
1.0 0.99–1.1 0.99 0.97–0.99 1.0 0.95–1.01
4.0 1.2–17 2.2 1.6–2.9 0.5 0.2–1.2
1 1 1
1.1 0.4–3.4 0.8 0.6–1.1 1.3 0.5–3.1
1.1 0.3–3.5 0.9 0.7–1.3 1.0 0.3–3.0
0.4 0.2–1.2 0.7 0.5–0.9 1.6 0.7–4.0
1.7 0.5–6.1 1.0 0.7–1.4 2.0 0.7–5.2
4.6 1.4–16 1.9 1.4–2.6 3.8 1.5–9.6
2.0 1.7–2.3 0.9 0.5–1.3 1.4 0.9–1.8
0.26 0.51 0.20
mer-Lemeshow.
Fig. 2. Longitudinal change of white blood cell (A) and neutrophil (B) counts in healthy
adults divided by quitting or continuing cigarette smoking. In individuals who were
current smokers at the ﬁrst visit (year 0) and quitted smoking before the second visit
(year 1) and remained abstinent for at least next two years, both white blood cell
(WBC) and neutrophil counts signiﬁcantly decreased within one year (P = 0.001 for
WBC and 0.005 for neutrophil counts, respectively, Paired t-test) and remained decreased
for the abstinent period (squares and dotted lines). On the other hands, both WBC and
neutrophil counts did not change in individuals who continued smoking during the
same period (circles and straight lines). N. S., not signiﬁcant.
420 T. Higuchi et al. / Preventive Medicine Reports 4 (2016) 417–422and the association was maintained after two years (adjusted OR, 1.55;
95% CI, 1.44–1.67) (Table 5).
Effects of smoking cessation on neutrophil and lymphocyte counts
were studied in longitudinal study. Neutrophil count decreased signiﬁ-
cantly after smoking cessation in one year (P = 0.005) and remained
down-regulated after the following two years, however, it did not
change among continuing smokers (Fig. 2B). The lymphocyte count
also decreased in one year after smoking cessation, however, the differ-
ence from baseline was not signiﬁcant (P = 0.082) with no further
changes after the following two years. These results indicated that
smoking cessation lead to decreases in totalWBC and neutrophil counts
in one year and these effects remained for longer than next two years.
BMI of the quitters was signiﬁcantly increased from baseline (mean,
22.65 kg/m2) in one year (mean, 23.0 kg/m2; P b 0.0001) and, as the pe-
riod of abstinence became longer, BMI further increased during next
two years (mean, 23.26 kg/m2; P b 0.0001). BMI of continuing smokers
did not change from baseline (mean, 22.86 kg/m2) in one year (mean,
22.85 kg/m2; P = 0.59), however, BMI increased signiﬁcantly in theTable 4
Factors associated with decrease in WBC count in one year since the ﬁrst visit.
Crude OR (95% CI)
Age at the ﬁrst visit 1.00 (0.99–1.01)
Male gender 0.97 (0.79–1.2)
Increase of BMI (kg/m2) 0.87 (0.72–1.05)
Smoking abstinence 1.56 (1.18–2.07)
Baseline WBC count (109/L) 1.35 (1.27–1.44)
Cigarettes/day 1.00 (0.99–1.01)
Hosmer-Lemeshow test, P= 0.81.
BMI, body mass index; WBC, white blood cell; OR, odds ratio.following two years (22.94 kg/m2; P b 0.0001). Increase of BMI in quit-
ters was not associated with decrease of WBC at the second visit (ad-
justed OR, 0.85; 95% CI, 0.70–1.03) (Table 4), however, was inversely
associated with decrease in WBC count two years later at the fourth
visit (adjusted OR, 0.73; 95% CI, 0.60–0.89) (Table 5), indicating that de-
crease in WBC count after smoking cessation was associated with de-
crease of BMI.
4. Discussion
Our study demonstrated that younger age, male gender, increased
BMI, no habit of alcohol drinking, and current smoking were signiﬁ-
cantly associatedwith increasedWBC count. This increasewas reversed
by quitting smoking in one year and continued to be down-regulated at
least for the following two years. The questionnaire did not include the
question when the quitters stopped smoking and we could not obtain
the exact date of smoking cessation and, thus, the duration of the absti-
nence of the quitters before the second visit differed in each individual.
Accordingly, the precise time-dependent changes of WBC count within
one year after the smoking cessation could not be studied in detail.
Nonetheless, these ﬁndings clearly demonstrated that the effect of
smoking cessation on WBC count became apparent in one year and
lasted at least for the following two years.
Elevated WBC count has been reported to be associated with CHD
(Imano et al., 2007; Madjid et al., 2004) and cardiovascular mortality
(Brown et al., 2001; Jee et al., 2005; Tamakoshi et al., 2007) and has
been identiﬁed as an independent risk factor of CHD (Brown et al.,
2001; Madjid et al., 2004). Elevated WBC count is also associated with
components of metabolic syndrome, which is a well-known risk factor
for CHD/CVD (Nagasawa et al., 2004; Kim et al., 2008; Yanbaeva et al.,
2007). Therefore, detection of the cause of elevated WBC count and its
reductionmay be expected to contribute to the prevention of CHD/CVD.
While there have been several reports which did not support the as-
sociation between male gender and elevated WBC count (Schwarz and
Weiss, 1994), the rest of ourﬁndingswere compatiblewith previous re-
ports (Schwartz and Weiss, 1991; Nagasawa et al., 2004; Brown et al.,
2001; Herishanu et al., 2006; Jee et al., 2005; Imano et al., 2007; Lee
et al., 2009; Nakanishi et al., 2003). Of note is that the result of the
cross-sectional study demonstrated positive association between in-
creased BMI and elevated WBC count as previously reported
(Schwartz and Weiss, 1991; Nagasawa et al., 2004; Herishanu et al.,
2006; Jee et al., 2005; Imano et al., 2007) and, in addition, the associa-
tion was conﬁrmed by multivariate logistic regression analysis in the
longitudinal study.
The association between elevatedWBC count and cigarette smoking,
a well-established cardiovascular risk factor, has been reported inmany
epidemiological studies and also it has been reported that smoking ces-
sation leads to a reduction in WBC counts (Petitti and Kipp, 1986;
Yarnell et al., 1987; Schwartz and Weiss, 1991; Schwarz and Weiss,
1994; Freedman et al., 1996; Sunyer et al., 1996; Van Tiel et al., 2002;
Fröhlich et al., 2003; Smith et al., 2003; Lao et al., 2009). Elevated WBC
count may reﬂect the existence of low-grade inﬂammatory response
in smokers (Lee et al., 2009; Yanbaeva et al., 2007) and it is assumed
that reduction in WBC count reﬂects the improvement of the systemicP value Adjusted OR (95% CI) P value
0.43
0.81
0.14 0.85 (0.70–1.03) 0.095
0.002 1.85 (1.39–2.48) b0.0001
b0.0001 1.37 (1.28–1.46) b0.0001
0.52
Table 5
Factors associated with decrease in WBC count at the fourth visit.
Crude OR (95% CI) P value Adjusted OR (95% CI) P value
Age at the ﬁrst visit 1.01 (0.999–1.02) 0.097 1.01 (0.995–1.02) 0.29
Male gender 1.00 (0.81–1.24) 0.97
Increase of BMI (kg/m2) 0.78 (0.65–0.95) 0.012 0.73 (0.60–0.89) 0.002
Smoking abstinence 1.91 (1.44–2.55) b0.0001 2.54 (1.88–3.46) b0.0001
Baseline WBC count (109/L) 1.51 (1.41–1.62) b0.0001 1.55 (1.44–1.67) b0.0001
Cigarettes/day 1.01 (0.996–1.02) 0.25
Hosmer-Lemeshow test, P= 0.51.
BMI, body mass index; WBC, white blood cell; OR, odds ratio.
421T. Higuchi et al. / Preventive Medicine Reports 4 (2016) 417–422inﬂammation and, possibly, of vascular endothelial inﬂammation. The
association between elevated CRP level and elevated WBC count ob-
served in the cross-sectional study and the decrease in neutrophils in
one year after smoking cessation support these assumptions. Moreover,
WBCs are, by themselves, considered to be involved in vascular injury
through pressure dependent plugging of microvessels by WBCs, rheo-
logical abnormalities, increased adhesiveness, and release of substances
resulting in cytotoxic injury to the vesselwall (Brown et al., 2001). Thus,
the reduction in WBC count may reﬂect the alleviation of the vascular
damage caused by WBCs. In addition to these possible direct damage
to the vascular system, increasedWBCs may contribute to the develop-
ment of CHD and CVD indirectly through modiﬁcation of various risk
factors such as HBP (Nagasawa et al., 2004; Brown et al., 2001; Jee
et al., 2005; Imano et al., 2007; Lee et al., 2009), hyperlipidemia
(Nagasawa et al., 2004; Jee et al., 2005), and diabetes (Nagasawa et al.,
2004; Jee et al., 2005).
In these contexts, it should be emphasized that not only neutrophils
and monocytes, which were associated with elevated CRP, but also the
other differentials were elevated in current smokers. These observa-
tions indicate that smoking habit leads to increase of all components
of WBC by mechanisms not elucidated yet. These observations have
not been reported before.
Though it has been reported that changes in smoking habit inﬂuence
WBC count and smoking cessation leads to a decrease in WBC count,
which depends on the duration of the smoking abstinent (Petitti and
Kipp, 1986; Yarnell et al., 1987; Schwarz and Weiss, 1994; Van Tiel
et al., 2002; Smith et al., 2003), there have been only a few longitudinal
studies which investigated the effect of smoking cessation on WBC
count (Sunyer et al., 1996; Jensen et al., 1998; Green and Harari,
1995). Especially regarding the Asian population, only one cross-
sectional study reported the effects of smoking on WBC count among
Japanese adults (Kawada, 2004) and the effect of smoking cessation
on WBC count has not been studied longitudinally. This report is the
ﬁrst studywhich evaluated the longitudinal effects of smoking cessation
in a large Asian population and clearly demonstrated the association be-
tween smoking cessation and decrease in WBC count.
There are some limitations in our study. First, this is a retrospective
study and theremay be an information bias as the data on smoking sta-
tus were collected and evaluated based on the self-reported question-
naire. Second, study participants of this longitudinal study were those
who had health check-ups for at least consecutive four years. These par-
ticipants are estimated to be more conscious about their health status
than general populations. Third, there was no information about medi-
cation used for smoking cessation. As it has been reported that WBC
count decreased after cessation of smokingwith use of nicotine replace-
ment (Jensen et al., 1998; Eliasson et al., 2001), we cannot exclude the
possibility that WBC count decreased by taking such medication. How-
ever, as the WBC count remained down-regulated for more than two
years after smoking cessation, we think that the effects of such medica-
tionwereminimal if some of the quitters actually used it. Fourth, as this
is a retrospective observational study of participants of general health
check-ups, important factors which might inﬂuence WBC counts were
not evaluated, thus, our results did not allowus to attempt to investigatescientiﬁc explanation of the association between cigarette smoking and
WBCcount, forwhich studies beyond the frame of general health check-
up should be performed. Fifth, one of Hosmer-Lemeshow tests was sig-
niﬁcant (Table 1) but this would be due to large sample number.
There are some criteria proposed to show causal association. One of
these criteria is strong association and temporal relationship where
cause precedes the outcome (Grobbee, 2009). Our study supported
temporal relationship between smoking cessation and decrease in
WBC count by adding longitudinal study to cross-sectional study. This
shall be the strength of our study.
In conclusion, current smoking is strongly associated with elevated
WBC count in healthy adults with increase of all WBC differentials.
Smoking cessation is associated with recovery of WBC count in one
year and this effect lasts for at least next two years. It is important to
keep in mind that cigarette smoking is one of differential diagnoses
and a reversible cause of elevated WBC count.
Conﬂicts of interest
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